Literature DB >> 27245019

[Analysis of the allergic reaction types of Chinese medicine injection based on immunotoxicty].

Zhi-fei Wang, Qing-hua Ai, Yuan-yuan Li, Jun-jie Jiang, Lian-xin Wang, Wei Yang, Yan-ming Xie.   

Abstract

The purpose of the study is to find the allergic reaction types and characteristics of Chinese medicine injection ( CMI). The authors monitored patients who used Shuxuetong injection, Dengzhan Xixin injection, Shenqi Fuzheng injection, Shenmai injection, Ciwujia injection, Shuxuening injection, Tanreqing injection, Reduning injection, a total of 150,000 cases were monitored. They used a nested case-control design to group the patients and obtained the serum samples from 14 allergic patients and 55 matched patients. They used enzyme-linked immunosorbent assay (ELISA) to detect serum C3, C4, IgE, IgG, MCT-P, and judge the allergic reaction types: Shuxuetong injection hypersensitivity (1 case), can not determine (1 case); Dengzhan Xixin injection hypersensitivity (1 case), hypersensitivity & anaphylactoid reaction (1 case), can not determine (1 case); Shenqi Fuzheng injection hypersensitivity (3 cases), can not determine (1 case); Shenmai injection anaphylactoid reaction (1 case); Ciwujia injection can not determine (1 case), Shuxuening injection can not determine (1 case), Tanreqing injection can not determine (1 case), Reduning injection can not determine (1 case). The results showed that the main type of allergic reaction of CMI was hypersensitivity, the type of allergic reaction was closely related to the varieties of CMI, the hypersensitivity and anaphylactoid reaction might occur in one patient at the same time which used Dengzhan Xixin injection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27245019

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  3 in total

1.  Macromolecular substances as a dangerous factor in traditional Chinese medicine injections were determined by size-exclusive chromatography.

Authors:  Yue Li; Jinlian Duan; Heng Xia; Bin Shu; Weigang Duan
Journal:  Toxicol Res (Camb)       Date:  2020-05-21       Impact factor: 3.524

2.  Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations.

Authors:  Can Wang; Qing-Ping Shi; Feng Ding; Xiao-Dong Jiang; Wei Tang; Mei-Ling Yu; Jian-Hua Zhu
Journal:  Drug Des Devel Ther       Date:  2018-04-05       Impact factor: 4.162

3.  Chlorogenic acid in the oxidative stress injury triggered by Shuang-Huang-Lian injection.

Authors:  Wen-Yuan Du; Ying Xiao; Jian-Jing Yao; Zhe Hao; Yu-Bin Zhao
Journal:  Exp Ther Med       Date:  2018-08-02       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.